We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Tissue Sealer Improves Efficiency During Laparoscopic Procedures

By HospiMedica International staff writers
Posted on 03 Mar 2014
Print article
Image: The LigaSure Maryland Jaw open jaw vessel sealer and divider (Photo courtesy of Covidien).
Image: The LigaSure Maryland Jaw open jaw vessel sealer and divider (Photo courtesy of Covidien).
A new open jaw vessel sealer and divider allows surgeons to grasp, seal, and cut tissue with minimal steps and reduced instrument exchanges.

The LigaSure Maryland Jaw combines energy-based vessel sealing technology with the functionality of three common surgical tools - a Maryland dissector, which is a blunt surgical tool with a curved jaw used to separate, grasp and manipulate tissue; an atraumatic tissue grasper; and cold surgical scissors. The device is designed for use in minimally invasive procedures including urologic, vascular, thoracic and thoracoscopic, and gynecologic procedures where ligation and division of the vessels is performed.

The vessel sealing technology is powered by proprietary ForceTriad energy platform, controlled by TissueFect sensing technology, which monitors changes in tissue 3,333 times per second, adjusting energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect. The technology uses the body’s own collagen and elastin to create a permanent fusion zone, including vessels up to and including 7 mm in diameter, lymphatics, tissue bundles, and pulmonary vasculature.

The LigaSure Maryland jaw device is a product of Covidien (Dublin, Ireland) and comes in three lengths; a 37 cm version, which will be available in early 2014, and 23 cm and 44 cm options which will be available later in the year. The LigaSure Maryland jaw device has received the approval of the US Food and Drug Administration (FDA), as well as completing all European community requirements to receive the CE marking of approval.

“For more than 15 years, surgeons have trusted LigaSure technology for its ability to reduce blood loss, shorten procedure time, and shorten the length of hospital stay compared to sutures,” said Chris Barry, president of advanced surgical devices at Covidien. “The LigaSure Maryland jaw offers surgeons an efficient, versatile, and multifunctional option for one-step sealing and further demonstrates Covidien’s commitment to expand energy device options with solutions targeted at specific procedures and surgeon use needs.”

Related Links:

Covidien


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Display
i3 Series

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.